Zivo Bioscience, Inc. (ZIVO): Total Liabilities
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$2.16M
As of 2024-12-31
$3.85M
As of 2025-09-30
-9.9%
3-year compound annual growth
-24.3%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $2.16M | -21.9% | 2025-03-18, Balance as of period end |
| 2023-12-31 | $2.76M | +29.4% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $2.13M | -27.6% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $2.95M | -74.4% | 2023-03-14, Balance as of period end |
| 2020-12-31 | $11.53M | +32.4% | 2022-04-22, Balance as of period end |
| 2019-12-31 | $8.71M | -61.6% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $22.69M | +36.4% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $16.64M | n/c | 2019-02-12, Balance as of period end |
| 2016-12-31 | $14.36M | +50.0% | 2018-02-21, Balance as of period end |
| 2015-12-31 | $9.57M | +47.9% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $6.47M | -45.0% | 2016-03-29, Balance as of period end |
| 2013-12-31 | $11.77M | +180.9% | 2015-04-06, Balance as of period end |
| 2012-12-31 | $4.19M | +67.9% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $2.49M | +93.2% | 2013-03-25, Balance as of period end |
| 2010-12-31 | $1.29M | n/a | 2012-03-30, Balance as of period end |